Atogepant-impurities | Pharmaffiliates

Atogepant and its Impurities

Atogepant is under investigation in clinical trial NCT03855137 (Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine). Reference standards of Atogepant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Atogepant Impurities
PA 01 3310000

Atogepant - API Standards

Atogepant

  • Catalogue No.:PA 01 3310000

  • CAS :

    1374248-81-3

  • Molecular Formula : C29H23F6N5O3

  • Molecular Weight : 603.53

Enquire
Details
PA 01 3311000

Tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate

Tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate

  • Catalogue No.:PA 01 3311000

  • CAS :

    1456803-42-1

  • Molecular Formula : C17H21F3N2O3

  • Molecular Weight : 358.36

Enquire
Details
PA 01 3311001

Isopropyl 2-((tert-butoxycarbonyl)amino)-5-oxo-4-(2,3,6-trifluorophenyl)hexanoate

Isopropyl 2-((tert-butoxycarbonyl)amino)-5-oxo-4-(2,3,6-trifluorophenyl)hexanoate

  • Catalogue No.:PA 01 3311001

  • CAS :

    1488326-89-1

  • Molecular Formula : C20H26F3NO5

  • Molecular Weight : 417.43

Enquire
Details
Tools

Calculators

Normality Dilution Mass molarity
Periodic Table- Pharmaffiliates

Periodic Table

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help